Publications by authors named "Eleonora Capannini"
Article Synopsis
- The study aims to evaluate how changing therapy days for haemophilia B medications could affect spending compared to 2022.
- It analyzes data on all coagulation factor IX products used in Italy to estimate potential cost changes by switching 5% to 20% of therapy days to a new treatment, nonacog beta pegol.
- Results suggest that overall spending on haemophilia B treatments may stay the same or decrease slightly (by up to 2.26%), contrasting with previous years' increasing costs, indicating the need for better pharmaceutical management.
Background: The aim of the study is to compare the obstetric outcome between single pregnancies obtained by medically-assisted procreation using oocyte donors (MAP-E) versus homologous gametes (MAP-O) and single spontaneous conception pregnancies (SC).
Methods: This is a retrospective case-control study on pregnancy outcome of consecutive singleton live birth pregnancies from MAP-E between January 2011 and August 2017 referred to Careggi University Hospital, Florence. The control group includes singleton pregnancies from MAP-O and pregnancies from spontaneous conceptions in the same period.
Introduction: Decision-making in healthcare should rely on evidence-based approaches able to make possible a transparent and robust assessment of all the aspects related to health technologies. One of the assessment elements is represented by the efficiency that is the specific objective of economic evaluations and also of Health Technology Assessment (HTA). The collection and synthesis of evidence is the first indispensable step in order to foster a proper convey of scientific knowledge to the decision-makers.
View Article and Find Full Text PDF